T-piece Versus Pressure-support for the Spontaneous Breathing Trial
NCT ID: NCT04227639
Last Updated: 2022-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2020-01-31
2021-09-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To do that, the study director proposed to conduct a prospective multicenter randomized controlled open-label trial comparing these 2 strategies of weaning in patients at high-risk of extubation failure in the Intensive Care Unit.
Patients included will be randomized before performing the first spontaneous breathing trial and will be assigned to one of the following two groups according to the weaning strategy: T-piece trial group or Pressure-Support trial group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial
NCT03861117
ONE-HOUR POSITIVE PRESSURE VENTILATION AFTER A T-PIECE SPONTANEOUS BREATHING TRIAL: A RANDOMIZED CLINICAL TRIAL
NCT07324382
Ventilation Strategies During Spontaneous Breathing Trial
NCT02939963
Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure
NCT07019636
ONE-HOUR POSITIVE PRESSURE VENTILATION AFTER A PRESSURE SUPPORT SPONTANEOUS BREATHING TRIAL: A RANDOMIZED CLINICAL TRIAL
NCT07324460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T-piece trial
In patients assigned to control group all spontaneous breathing trials will be performed using T-piece trial.
T-piece trial
T-piece trial will be performed for around 1 hour with a T-piece connected to the extremity of the endotracheal tube by simply disconnecting the patient from the ventilator and by providing additional oxygen (≤ 6 L/min)
Pressure-Support trial
In patients assigned to experimental group all spontaneous breathing trials will be performed with a pressure-support level of 8 cm H2O without positive end-expiratory pressure.
Pressure-support trial
Pressure-Support trial will be performed for around 1 hour without disconnecting the patient from the ventilator, by using a low level of pressure-support (PS 8 cm H2O) with a FiO2 ≤ 40% and without positive end-expiratory pressure (PEEP), while continuously monitoring the respiratory rate and tidal volume on the ventilator display.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
T-piece trial
T-piece trial will be performed for around 1 hour with a T-piece connected to the extremity of the endotracheal tube by simply disconnecting the patient from the ventilator and by providing additional oxygen (≤ 6 L/min)
Pressure-support trial
Pressure-Support trial will be performed for around 1 hour without disconnecting the patient from the ventilator, by using a low level of pressure-support (PS 8 cm H2O) with a FiO2 ≤ 40% and without positive end-expiratory pressure (PEEP), while continuously monitoring the respiratory rate and tidal volume on the ventilator display.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients at high-risk of reintubation according to the following criteria: Patients older than 65 years, or those having any underlying chronic cardiac or lung disease.
3. Patient meeting all weaning criteria according to the international conference consensus on weaning.
* Respiratory rate ≤ 35 breaths per minute,
* Adequate oxygenation defined as SpO2 \> 90% with FiO2 ≤ 0.4 or PaO2/FiO2 \> 150 mm Hg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O,
* Adequate cough,
* Patient awake with a Richmond Agitation-Sedation Scale between +1 and -2
* No continuous sedation,
* Hemodynamic stability with no need for vasopressors (or minimal dosis).
4. Informed consent given by the relatives or the patient himself.
Exclusion Criteria
2. Pre-existing peripheral neuromuscular disease (underlying myopathy or myasthenia gravis)
3. Do-not-reintubate order at time of the first spontaneous breathing trial
4. Patient previously included in the study
5. No Health insurance coverage
6. People under protection: Pregnant or breastfeeding women, minor patients, subjects with guardianship or under law protection.
7. Refusal to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud W. THILLE, Pr
Role: PRINCIPAL_INVESTIGATOR
CHU Poitiers
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Intensive reanimation
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Coudroy R, Lejars A, Rodriguez M, Frat JP, Rault C, Arrive F, Le Pape S, Thille AW. Physiologic Effects of Reconnection to the Ventilator for 1 Hour Following a Successful Spontaneous Breathing Trial. Chest. 2024 Jun;165(6):1406-1414. doi: 10.1016/j.chest.2024.01.038. Epub 2024 Jan 29.
Thille AW, Gacouin A, Coudroy R, Ehrmann S, Quenot JP, Nay MA, Guitton C, Contou D, Labro G, Reignier J, Pradel G, Beduneau G, Dangers L, Saccheri C, Prat G, Lacave G, Sedillot N, Terzi N, La Combe B, Mira JP, Romen A, Azais MA, Rouze A, Devaquet J, Delbove A, Dres M, Bourenne J, Lautrette A, de Keizer J, Ragot S, Frat JP; REVA Research Network. Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece. N Engl J Med. 2022 Nov 17;387(20):1843-1854. doi: 10.1056/NEJMoa2209041. Epub 2022 Oct 26.
Thille AW, Coudroy R, Gacouin A, Ehrmann S, Contou D, Dangers L, Romen A, Guitton C, Lacave G, Quenot JP, Lacombe B, Pradel G, Terzi N, Prat G, Labro G, Reignier J, Beduneau G, Dellamonica J, Nay MA, Rouze A, Delbove A, Sedillot N, Mira JP, Bourenne J, Lautrette A, Argaud L, Levrat Q, Devaquet J, Vivier E, Azais MA, Leroy C, Dres M, Robert R, Ragot S, Frat JP; REVA research network. T-piece versus pressure-support ventilation for spontaneous breathing trials before extubation in patients at high risk of reintubation: protocol for a multicentre, randomised controlled trial (TIP-EX). BMJ Open. 2020 Nov 24;10(11):e042619. doi: 10.1136/bmjopen-2020-042619.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02151-56
Identifier Type: OTHER
Identifier Source: secondary_id
TiP-Ex
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.